Interactions of anti-rheumatic drugs
Brooks, P.M.; Bell, M.A.; Mason, D.I.; Buchanan, W.W.
Agents and Actions. Supplements 1977(1): 85-95
1977
ISSN/ISBN: 0379-0363 PMID: 272827 Document Number: 113958
Document emailed within 1 workday
Related Documents
Abruzzo, J.L. 1978: Newer anti-rheumatic drugs Annals of Internal Medicine 89(1): 131-133Willoughby, D.A. 1988: The changing pattern in the search for new anti-rheumatic drugs Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 3(Suppl 1): 67-70
Olhagen, B. 1985: Non-steroidal anti-inflammatory drugs in the treatment of rheumatic diseases Nordisk Medicin 100(1): 11-13
Kovarsky, J. 1985: Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis Texas Medicine 81(9): 35-39
Willoughby, D.A. 1989: The changing philosophy in the search for anti-rheumatic drugs: a personal overview International Journal of Tissue Reactions 11(5): 205-212
Kucharz, E.; Stawiarska, B.; Drozdz, M. 1982: Influence of anti-rheumatic drugs on the activity of collagenolytic cathepsin in hepatic culture Acta Biologica et Medica Germanica 41(1): 39-46
Handwerker, H.O. 1991: Assessment of the effect of ibuprofen and other non-steroidal anti-rheumatic drugs in experimental algesimetry Zeitschrift für Rheumatologie 50(Suppl 1): 15-18
Scott, I.C.; Kingsley, G.H.; Scott, D.L. 2013: Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis? Clinical and Experimental Rheumatology 31(4 Suppl 78: S4-S8
Hauss, W.H.; Mey, J.; Schulte, H. 1979: The effect of pathogenic factors and anti-rheumatic drugs on the proliferation of cultured human fibroblasts Zeitschrift für Rheumatologie 38(5-6): 220-232
Magarò, M.; Altomonte, L.; Zoli, A.; Mirone, L.; Berchicci, M.C.; Tricerri, A.; Corvino, G. 1989: Asymptomatic and symptomatic gastroduodenal patients affected by rheumatic disease treated with non-steroidal anti-inflammatory drugs Panminerva Medica 31(1): 16-18
Menard, H.A.; Mathieu, J.P.; de Medicis, R.; Lussier, A. 1979: Slow onset anti-rheumatic drugs in rheumatoid arthritis: could the presence of antinuclear antibody influence the therapeutic results? Journal of Rheumatology 6(2): 156-162
Gibofsky, A.; Cannon, G.W.; Harrison, D.J.; Joseph, G.J.; Bitman, B.; Chaudhari, S.; Collier, D.H. 2015: Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2) Clinical and Experimental Rheumatology 33(3): 297-301
Kumar, S.; Rao, P.S.S.; Earla, R.; Kumar, A. 2015: Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems Expert Opinion on Drug Metabolism and Toxicology 11(3): 343-355
Simon, B.; Leucht, U.; Amon, I.; Brandau, J.; Müller, P. 1993: Nizatidine in therapy and prevention of non-steroidal anti-rheumatic drug-induced ulcers in rheumatic patients Zeitschrift für Gastroenterologie 31(6): 395-400
Fialová, P.; Vlcek, J. 2004: The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs Vnitrni Lekarstvi 50(11): 858-866
Neubert, R.; Fritsch, B.; Dongowski, G. 1995: Interactions between food components and drugs. Part 3. Interactions between pectin and propranolol Die Pharmazie 50(6): 414-416
Ristić, A.; Stern, P. 1974: Anti-inflammatory and anti-rheumatic effect of Fojnica's mineral water Reumatizam 21(6): 231-233
Blichfeldt, P. 1975: Antiinflammatory drugs--Use of cytostatic drugs in rheumatic diseases Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 95(28): 1606-1608
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
Komai-Koma, M.; Liew, F.Y.; Wilkinson, P.C. 1995: Interactions between IL-4, anti-CD40, and anti-immunoglobulin as activators of locomotion of human B cells Journal of Immunology 155(3): 1110-1116